Skip navigation

Utilize Predictive Methodologies to Reduce Amendments, Increase Forecast Accuracy and Improve Trial Timelines

February 8-9, 2016
  • Philadelphia, PA

CPE
Credits
Available Pending Approval

Join CBI for its 7th Annual Clinical Trial Budgeting & Forecasting conference to identify solutions and best practices for ensuring accurate and effective budgeting, forecasting and management of clinical trials. This conference will help bridge the gap bridge between clinical finance, operations and project management. With the continuing rise in clinical trial costs, clinical teams are under extreme pressure to complete their trials on time and within budget.

FEATURING:

KEYNOTE ADDRESS
Evaluate Financial Strategies to Reallocate Funds across the Portfolio to Achieve Overall Budget

Sean Gharpurey
Executive Director,
R&D Business Excellence
Jazz Pharmaceuticals

CONFERENCE CHAIR:

Debbie Walsh
MRL Finance Director
Merck

 

Tools and Practical Insight for Improved Financial Planning and Data-Driven Budgets

  • Leverage an evidence-based approach to create a forecast budget that is more predictive than reactive
  • Effectively contract with central labs by incorporating milestones in protocol
  • Apply spend analysis to avoid delays resulting from seeking additional funding approvals mid-study
  • Structure CRO contracts to include monitoring to facilitate better accruals
  • Utilize internal and external benchmarking data to build study budgets
  • Investigate the common accruals that can significantly impact the trial’s financial forecast

PLUS! Choose from Two Pre-conference Workshops

A: Budget Development Best Practices
B: Financial Forecasting and Accrual Methodologies

Featured Perspectives from:

ACM Global Central Laboratory
Bristol-Myers Squibb Celgene
FibroGen Inc. Merck
Merrimack Pharmaceuticals
Upsher-Smith Laboratories
And More!

Previous Attendee Acclaim

Felt like the speakers were addressing me directly.

Manager, Clinical Outsourcing, Astex Pharmaceuticals

This conference validated we all have the same issues to deal with and many of us are using similar approaches.

Finance Director, Merck

Content and interactions were engaging, relevant and revealing.

Clinical Operations Contractor, Upsher-Smith Laboratories

February 8-9, 2016 Wyndham Historic District Philadelphia, PA

Clinical Trial Budgeting and Forecasting

Utilize Predictive Methodologies to Reduce Amendments, Increase Forecast Accuracy and Improve Trial Timelines

CPE
Credits
Available Pending Approval

Join CBI for its 7th Annual Clinical Trial Budgeting & Forecasting conference to identify solutions and best practices for ensuring accurate and effective budgeting, forecasting and management of clinical trials. This conference will help bridge the gap bridge between clinical finance, operations and project management. With the continuing rise in clinical trial costs, clinical teams are under extreme pressure to complete their trials on time and within budget.

FEATURING:

KEYNOTE ADDRESS
Evaluate Financial Strategies to Reallocate Funds across the Portfolio to Achieve Overall Budget

Sean Gharpurey
Executive Director,
R&D Business Excellence
Jazz Pharmaceuticals

CONFERENCE CHAIR:

Debbie Walsh
MRL Finance Director
Merck

 

Tools and Practical Insight for Improved Financial Planning and Data-Driven Budgets

  • Leverage an evidence-based approach to create a forecast budget that is more predictive than reactive
  • Effectively contract with central labs by incorporating milestones in protocol
  • Apply spend analysis to avoid delays resulting from seeking additional funding approvals mid-study
  • Structure CRO contracts to include monitoring to facilitate better accruals
  • Utilize internal and external benchmarking data to build study budgets
  • Investigate the common accruals that can significantly impact the trial’s financial forecast

PLUS! Choose from Two Pre-conference Workshops

A: Budget Development Best Practices
B: Financial Forecasting and Accrual Methodologies

Featured Perspectives from:

ACM Global Central Laboratory
Bristol-Myers Squibb Celgene
FibroGen Inc. Merck
Merrimack Pharmaceuticals
Upsher-Smith Laboratories
And More!

Previous Attendee Acclaim

Felt like the speakers were addressing me directly.

Manager, Clinical Outsourcing, Astex Pharmaceuticals

This conference validated we all have the same issues to deal with and many of us are using similar approaches.

Finance Director, Merck

Content and interactions were engaging, relevant and revealing.

Clinical Operations Contractor, Upsher-Smith Laboratories

February 8-9, 2016 Wyndham Historic District Philadelphia, PA